Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
23,177,080
-
Share change
-
-22,045
-
Total reported value
-
$112,175,583
-
Put/Call ratio
-
2%
-
Price per share
-
$4.84
-
Number of holders
-
75
-
Value change
-
-$609,875
-
Number of buys
-
36
-
Number of sells
-
43
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q3 2020
As of 30 Sep 2020,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,177,080 shares.
The largest 10 holders included
Bellevue Group AG, FRANKLIN RESOURCES INC, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, Cormorant Asset Management, LP, Opaleye Management Inc., MILLENNIUM MANAGEMENT LLC, Candriam Luxembourg S.C.A., and Alyeska Investment Group, L.P..
This page lists
75
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.